Virtual Reality Game to Ease Pain and Fear During Children's Eczema Injections
Tests a virtual reality game to reduce pain and fear in children receiving eczema injections.
Plain-language title generated from the registry record
Registry title: Virtual Reality for Pain Management During Dupilumab Injection
Key facts
- Where
- Montreal, CanadaSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 17 years old?
Source: NCT06182436, who can take part
Where in Canada
- CHU Sainte-JustineMontreal, CanadaTaking people
- St. Justine's HospitalMontreal, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- St. Justine's Hospital
- Trial code
- NCT06182436
- Record updated
- 24 August 2025
- Original description
The aim of this within-subject randomized study is to examine the efficacy of a VR immersive game for pain and anxiety management of children during the subcutaneous injection of dupilumab for moderate to severe atopic dermatitis. We will recruit children from 6 to 17 years.Read full original descriptionShow less
Use of Virtual Reality to Improve Pain and Anxiety Management of Children During Dupilumab Injection for Atopic Dermatitis (VR-DERMA)
The aim of this within-subject randomized study is to examine the efficacy of a VR immersive game for pain and anxiety management of children during the subcutaneous injection of dupilumab for moderate to severe atopic dermatitis. We will recruit children from 6 to 17 years.
The main research question is:
1. Does VR immersive game will generate less anxiety and pain than standard procedures, for children receiving dupilumab injection for moderate to severe atopic dermatitis? 2. Does the occurence of side effects is similar between both study groups?
Participants will be randomized according to either sequences: VR-Standard care or Standard care-VR. During the VR sequence, participants will be playing the VR immersive game during the injection. During the Standard care sequence participants will not benefit from any pain management but passive distraction tools will be offered (and documented) to children.
The investigators will take measures of pain and anxiety, using validated scales, before and after the procedures at each sequence.
Inclusion: between the ages of 6 to 17 years old,; suffering from moderate to severe atopic dermatitis and receiving or about to start subcutaneous injections of dupilumab,; in the presence of a consenting parent who can understand, read, and write either French or English.
Exclusion: have a diagnosed cognitive impairment precluding them from playing a virtual reality game,; suffer from epilepsy considering the nature of the intervention,; cannot be in a sitting position during the procedure as the virtual reality game requires an angle of at least 30 degrees for head-tracking.